Mengfei Guo

Key Laboratory Of Pulmonary Diseases Of National Health Commission, Union Hospital
Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Non-invasive prediction of invasive lung adenocarcinoma and high-risk histopathological characteristics in resectable early-stage adenocarcinoma by [18F]FDG PET/CT radiomics-based machine learning models: a prospective cohort study.

Non-invasive prediction of invasive lung adenocarcinoma and high-risk histopathological characteristics in resectable early-stage adenocarcinoma by [18F]FDG PET/CT radiomics-based machine learning models: a prospective cohort study.

Journal: International journal of surgery (London, England)

Published: April 22, 2025

Intratumoral immune-microbial crosstalk shaped by tumor cell-derived extracellular vesicles encapsulating berberine boosts lung cancer immunotherapy.

Intratumoral immune-microbial crosstalk shaped by tumor cell-derived extracellular vesicles encapsulating berberine boosts lung cancer immunotherapy.

Journal: Acta pharmaceutica Sinica. B

Published: March 17, 2025

Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment.

Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 05, 2025

Dendritic Cell Derived-Extracellular Vesicles Engineered to Express Interleukin-12 and Anti-CTLA-4 on Their Surface for Combinational Cancer Immunotherapy.

Dendritic Cell Derived-Extracellular Vesicles Engineered to Express Interleukin-12 and Anti-CTLA-4 on Their Surface for Combinational Cancer Immunotherapy.

Journal: Journal of extracellular vesicles

Published: April 19, 2024

Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway.

Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway.

Journal: Cell & bioscience

Published: November 16, 2023

Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinoma.

Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinoma.

Journal: Nature nanotechnology

Published: July 06, 2023

Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses.

Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses.

Journal: Journal for immunotherapy of cancer

Published: June 21, 2023

Phospholipid-Membrane-Based Nanovesicles Acting as Vaccines for Tumor Immunotherapy: Classification, Mechanisms and Applications.

Phospholipid-Membrane-Based Nanovesicles Acting as Vaccines for Tumor Immunotherapy: Classification, Mechanisms and Applications.

Journal: Pharmaceutics

Published: October 26, 2022

Metabolomics of Extracellular Vesicles: A Future Promise of Multiple Clinical Applications.

Metabolomics of Extracellular Vesicles: A Future Promise of Multiple Clinical Applications.

Journal: International journal of nanomedicine

Published: September 23, 2022

Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance.

Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance.

Journal: Frontiers in oncology

Published: September 12, 2022

Ischemia and reperfusion injury combined with cisplatin induces immunogenic cell death in lung cancer cells.

Ischemia and reperfusion injury combined with cisplatin induces immunogenic cell death in lung cancer cells.

Journal: Cell death & disease

Published: July 09, 2022

Role of macrophage in nanomedicine-based disease treatment.

Role of macrophage in nanomedicine-based disease treatment.

Journal: Drug delivery

Published: April 16, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026